Skip to main content
. 2022 Aug 19;18(6):514–523. doi: 10.4244/EIJ-D-21-00846

Figure1. Cumulative rates of recurrent hospitalisations for heart failure in the guideline-directed medical treatment (GDMT) and in the transcatheter mitral valve repair (TMVR) groups between 12 and 24 months after inclusion in the MITRA-FR trial.

Figure1

CI: confidence interval; HF: heart failure; RR: rate ratio